HbO2 Therapeutics
is a developer of hemoglobin based Hemopure for human application and Oxyglobin for veterinary application... Read moreHbO2 Therapeutics
is a developer of hemoglobin based Hemopure for human application and Oxyglobin for veterinary application... Read more
CEO
Zafiris G. Zafirelis
News
Apr 18, 2019
PR Newswire
Press Release: Hbo2 Therapeutics : Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature
Feb 13, 2019
PR Newswire
Press Release: Hbo2 Therapeutics : Hemoglobin Oxygen Therapeutics LLC Announce Updated Results From The Netherlands Leading Liver Transplant Hospital
Nov 08, 2018
PR Newswire
Press Release: Hbo2 Therapeutics : Hemopure® to be evaluated in groundbreaking clinical study of trauma patients in the prehospital setting, sponsored by the United States Department of Defense, and coordinated by Stellenbosch University
Oct 18, 2017
PR Newswire
Press Release: Hbo2 Therapeutics : Hemoglobin Oxygen Therapeutics LLC Announces the World's First Human Liver Transplantation After Ex-Situ Normothermic Machine Perfusion Using Hemopure®
